Portal de Periódicos da CAPES

COVID‐19 and neurodegeneration: what can we learn from the past?

2020; Wiley; Volume: 27; Issue: 9 Linguagem: Inglês

10.1111/ene.14311

1468-1331

Emilia Gatto, Julián Fernández Boccazzi,

Neuroinflammation and Neurodegeneration Mechanisms

European Journal of NeurologyVolume 27, Issue 9 p. e45-e45 Letters To The Editor COVID-19 and neurodegeneration: what can we learn from the past? E. M. Gatto, Corresponding Author E. M. Gatto [email protected] orcid.org/0000-0002-1346-5443 Departamento de Neurología, Sanatorio de la Trinidad Mitre, Ciudad Autonoma de Buenos Aires, Argentina Instituto de Neurociencias Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina Correspondence: E. M. Gatto, Juramento 1155 3ºA (CP: 1428) Buenos Aires, Argentina (tel.: 54 11 4785 30 97; fax: 54 1149547070 ext.291 ; e-mail: [email protected]).Search for more papers by this authorJ. Fernandez Boccazzi, J. Fernandez Boccazzi Departamento de Neurología, Sanatorio de la Trinidad Mitre, Ciudad Autonoma de Buenos Aires, ArgentinaSearch for more papers by this author E. M. Gatto, Corresponding Author E. M. Gatto [email protected] orcid.org/0000-0002-1346-5443 Departamento de Neurología, Sanatorio de la Trinidad Mitre, Ciudad Autonoma de Buenos Aires, Argentina Instituto de Neurociencias Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina Correspondence: E. M. Gatto, Juramento 1155 3ºA (CP: 1428) Buenos Aires, Argentina (tel.: 54 11 4785 30 97; fax: 54 1149547070 ext.291 ; e-mail: [email protected]).Search for more papers by this authorJ. Fernandez Boccazzi, J. Fernandez Boccazzi Departamento de Neurología, Sanatorio de la Trinidad Mitre, Ciudad Autonoma de Buenos Aires, ArgentinaSearch for more papers by this author First published: 12 May 2020 https://doi.org/10.1111/ene.14311Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Initial genome release of novel coronavirus. Available from http://virological.org/t/initial-genome-release-of-novel-coronavirus/319?from=groupmessage. (Accessed on 18 February 2020). Google Scholar 2Nath A. Neurologic complications of coronavirus infections. Neurology 2020; 94: 809–810. 10.1212/WNL.0000000000009455 CASPubMedWeb of Science®Google Scholar 3Beltrán-Corbellini Á, Chico-García JL, Martínez-Poles J, et al. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicenter PCR-based case–control study. Eur J Neurol 2020; 27: 1738–1741. 10.1111/ene.14273 Google Scholar 4Mori I. Viremic attack explains the dual-hit theory of Parkinson's disease. Med Hypotheses 2017; 101: 33–36. 10.1016/j.mehy.2017.02.007 PubMedWeb of Science®Google Scholar 5Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord 1992; 7: 153–158. 10.1002/mds.870070210 CASPubMedWeb of Science®Google Scholar 6Vilensky JA, Gilman S, McCall S. A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: a complex rather than a direct relationship. Mov Disord 2010; 25: 1116–1123. 10.1002/mds.22908 PubMedWeb of Science®Google Scholar Citing Literature Volume27, Issue9September 2020Pages e45-e45 ReferencesRelatedInformation